1.Akhmetova A, Saliev T, Allan IU, Illsley MJ, Nurgozhin T, Mikhalovsky S. A comprehensive review of topical odor-controlling treatment options for chronic wounds. J Wound Ostomy Continence Nurs. 2016;43:598–609.

2.Shirasu M, Nagai S, Hayashi R, Ochiai A, Touhara K. Dimethyl trisulfide as a characteristic odor associated with fungating cancer wounds. Biosci Biotechnol Biochem. 2009;73:2117–20.

3.Bowler PG, Davies BJ, Jones SA. Microbial involvement in chronic wound malodour. J Wound Care. 1999;8:216–8.

4.Dowsett C. Malignant fungating wounds: assessment and management. Br J Community Nurs. 2002;7:394–400.

5.Alexander S. Malignant fungating wounds: managing malodour and exudate. J Wound Care. 2009;18:374–82.

6.Hayashida K, Murakami C, Fujioka M. Palliative surgery for cutaneous ulcers improves the symptoms of patients with terminal cancer. J Palliat Med. 2013;16:831–2.

7.D’Abbondanza JA, Shahrokhi S. Burn infection and burn sepsis. Surg Infect (Larchmt). 2021;22:58–64.

8.Dokter J, Brusselaers N, Hendriks WDH, Boxma H. Bacteriological cultures on admission of the burn patient: to do or not to do, that’s the question. Burns. 2016;42:421–7.

9.Edwards-Jones V, Greenwood JE. What’s new in burn microbiology? Burns. 2003;29:15–24.

10.Li L, Dai JX, Xu L, Chen ZH, Li XY, Liu M, et al.  Antimicrobial resistance and pathogen distribution in hospitalized burn patients: a multicenter study in Southeast China. Medicine. 2018;97:e11977.

11.Wang LF, Li JL, Ma WH, Li JY. Drug resistance analysis of bacterial strains isolated from burn patients. Genet Mol Res. 2014;13:9727–34.

12.Fransén J, Huss FR, Nilsson LE, Rydell U, Sjöberg F, Hanberger H. Surveillance of antibiotic susceptibility in a Swedish burn Center 1994-2012. Burns. 2016;42:1295–303.

13.Yeong EK, Sheng WH, Hsueh PR, Hsieh SM, Huang HF, Ko AT, et al.  The wound microbiology and the outcomes of the systemic antibiotic prophylaxis in a mass burn casualty incident. J Burn Care Res. 2020;41:95–103.

14.Dankert J, Holloway Y, Bouma J, van der Werf J, Wolthers BG. Metronidazole in smelly gynaecological tumours. Lancet. 1981;2:1295.

15.Holloway S. Recognising and treating the causes of chronic malodorous wounds. Prof Nurse. 2004;19:380–4.

16.Ousey K, Roberts D, Gefen A. Early identification of wound infection: understanding wound odour. J Wound Care. 2017;26:577–82.

17.Manring MM, Hawk A, Calhoun JH, Andersen RC. Treatment of war wounds: a historical review. Clin Orthop Relat Res. 2009;467:2168–91.

18.Ashrafi M, Bates M, Baguneid M, Alonso-Rasgado T, Rautemaa-Richardson R, Bayat A. Volatile organic compound detection as a potential means of diagnosing cutaneous wound infections. Wound Repair Regen. 2017;25:574–90.

19.Fromantin I, Seyer D, Watson S, Rollot F, Elard J, Escande MC, et al.  Bacterial floras and biofilms of malignant wounds associated with breast cancers. J Clin Microbiol. 2013;51:3368–73.

20.Hayashida K, Ogino R, Yamakawa S, Shirakami E. Antiodor effects of rice bran sheets in patients with malodorous wounds. J Palliat Med. 2020;23:750–1.

21.Paul JC, Pieper BA. Topical metronidazole for the treatment of wound odor: a review of the literature. Ostomy Wound Manage. 2008;54:18–27 quiz 8-9.

22.Lund-Nielsen B, Adamsen L, Kolmos HJ, Rørth M, Tolver A, Gottrup F. The effect of honey-coated bandages compared with silver-coated bandages on treatment of malignant wounds-a randomized study. Wound Repair Regen. 2011;19:664–70.

23.Holloway S, Bale S, Harding K, Robinson B, Ballard K. Evaluating the effectiveness of a dressing for use in malodorous, exuding wounds. Ostomy Wound Manage. 2002;48:22–8.

24.Upright CA, Salton C, Roberts F, Murphy J. Evaluation of Mesalt dressings and continuous wet saline dressings in ulcerating metastatic skin lesions. Cancer Nurs. 1994;17:149–55.

25.Lucas Y, Niri R, Treuillet S, Douzi H, Castaneda BA. Wound size imaging: ready for smart assessment and monitoring. Adv Wound Care. 2020. Epub ahead of print.

26.Godwin ZR, Bockhold JC, Webster L, Falwell S, Bomze L, Tran NK. Development of novel smart device based application for serial wound imaging and management. Burns. 2013;39:1395–402.

27.Probert CS, Ahmed I, Khalid T, Johnson E, Smith S, Ratcliffe N. Volatile organic compounds as diagnostic biomarkers in gastrointestinal and liver diseases. J Gastrointestin Liver Dis. 2009;18:337–43.

28.Mellors TR, Rees CA, Franchina FA, Burklund A, Patel C, Hathaway LJ, et al.  The volatile molecular profiles of seven Streptococcus pneumoniae serotypes. J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1096:208–13.

29.Storer MK, Hibbard-Melles K, Davis B, Scotter J. Detection of volatile compounds produced by microbial growth in urine by selected ion flow tube mass spectrometry (SIFT-MS). J Microbiol Methods. 2011;87:111–3.

30.Tian FC, Xu XT, Shen Y, Yan J, He QH, Ma JW, et al.  Detection of wound pathogen by an intelligent electronic nose. Sen s Mater. 2009;21:155–66.

31.Darwin ES, Thaler ER, Lev-Tov HA. Wound odor: current methods of treatment and need for objective measures. G Ital Dermatol Venereol. 2019;154:127–36.

32.Villela-Castro DL, Santos VLCG, Woo K. Polyhexanide versus metronidazole for odor management in malignant (fungating) wounds: a double-blinded, randomized, clinical trial. J Wound Ostomy Continence Nurs. 2018;45:413–8.

33.George R, Prasoona TS, Kandasamy R, Cherian R, Celine T, Jeba J, et al.  Improving malodour management in advanced cancer: a 10-year retrospective study of topical, oral and maintenance metronidazole. BMJ Support Palliat Care. 2017;7:286–91.

34.Castro DL, Santos VL. Controlling wound odor with metronidazole: a systematic review. Rev Esc Enferm USP. 2015;49:858–63.

35.Trend MA, Jorgensen MA, Hazell SL, Mendz GL. Oxidases and reductases are involved in metronidazole sensitivity in helicobacter pylori. Int J Biochem Cell Biol. 2001;33:143–53.

36.Bower M, Stein R, Evans TR, Hedley A, Pert P. Coombes RC. A double-blind study of the efficacy of metronidazole gel in the treatment of malodorous fungating tumours. Eur J Cancer. 1992;28A:888–9.

37.Watanabe K, Shimo A, Tsugawa K, Tokuda Y, Yamauchi H, Miyai E, et al.  Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75% gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013). Support Care Cancer. 2016;24:2583–90.

38.McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12:147–79.

39.Hübner NO, Kramer A. Review on the efficacy, safety and clinical applications of polihexanide, a modern wound antiseptic. Skin Pharmacol Physiol. 2010;23:17–27.

40.Piatkowski A, Drummer N, Andriessen A, Ulrich D, Pallua N. Randomized controlled single center study comparing a polyhexanide containing bio-cellulose dressing with silver sulfadiazine cream in partial-thickness dermal burns. Burns. 2011;37:800–4.

41.Wu DJ, Figenshau K, Rajpara A, Aires DJ, Elston D. Sugar-based dressings for chronic wound care. J Am Acad Dermatol. 2020;82:e73.

42.Knutson RA, Merbitz LA, Creekmore MA, Snipes HG. Use of sugar and povidone-iodine to enhance wound healing: five year’s experience. South Med J. 1981;74:1329–35.

43.Murandu M, Webber MA, Simms MH, Dealey C. Use of granulated sugar therapy in the management of sloughy or necrotic wounds: a pilot study. J Wound Care. 2011;20:206 208, 210 passim.

44.Chiwenga S, Dowlen H, Mannion S. Audit of the use of sugar dressings for the control of wound odour at Lilongwe central hospital, Malawi. Trop Doct. 2009;39:20–2.

45.Lusby PE, Coombes A, Wilkinson JM. Honey: a potent agent for wound healing? J Wound Ostomy Continence Nurs. 2002;29:295–300.

46.Nair HKR, Tatavilis N, Pospíšilová I, Kučerová J, Cremers NAJ. Medical-grade honey kills antibiotic-resistant bacteria and prevents amputation in diabetics with infected ulcers: a prospective case series. Antibiotics (Basel). 2020;19:529.

47.Bayron J, Gallagher K, Cardenas L. Medical-grade honey as an alternative to surgery: a case series. Wounds. 2019;31:36–40.

48.Vandamme L, Heyneman A, Hoeksema H, Verbelen J, Monstrey S. Honey in modern wound care: a systematic review. Burns. 2013;39:1514–25.

49.Zbuchea A. Up-to-date use of honey for burns treatment. Ann Burns Fire Disasters. 2014;27:22–30.

50.Bigliardi PL, Alsagoff SAL, El-Kafrawi HY, Pyon JK, Wa CTC, Villa MA. Povidone iodine in wound healing: a review of current concepts and practices. Int J Surg. 2017;44:260–8.

51.Jeronimo LP, Choi MR, Yeon SH, Park SK, Yoon YH, Choi SH, et al.  Effects of povidone-iodine composite on the elimination of bacterial biofilm. Int Forum Allergy Rhinol. 2020;10:884–92.

52.Abboud EC, Legare TB, Settle JC, Boubekri AM, Barillo DJ, Marcet JE, et al.  Do silver-based wound dressings reduce pain? A prospective study and review of the literature. Burns. 2014;40:S40–7.

53.Percival SL, Thomas J, Linton S, Okel T, Corum L, Slone W. The antimicrobial efficacy of silver on antibiotic-resistant bacteria isolated from burn wounds. Int Wound J. 2012;9:488–93.

54.Khansa I, Schoenbrunner AR, Kraft CT, Janis JE. Silver in wound care-friend or foe?: a comprehensive review. Plast Reconstr Surg Glob Open. 2019;7:e2390.

55.Wiese F, Kutschan S, Doerfler J, Mathies V, Buentzel J, Buentzel J, et al.  Green tea and green tea extract in oncological treatment: a systematic review. Int J Vitam Nutr Res. 2021;17:1–13.

56.Haynes JS. A clinical evaluation of a charcoal dressing to reduce malodour in wounds. Br J Nurs. 2018;27:S36–42.

57.Park HY, Lee KW, Choi HD. Rice bran constituents: immunomodulatory and therapeutic activities. Food Funct. 2017;8:935–43.

58.Julião M, Calaveiras P, Costa E, Daniel S, Samorinha C, Faria de Sousa P. Antiodor effect of milled brown rice sheets in a malodorous cancer wound: a case report. J Palliat Med. 2021;24:175–6.

59.Taniguchi M, Ochiai A. Characterization and production of multifunctional cationic peptides derived from rice proteins. Biosci Biotechnol Biochem. 2017;81:634–50.

60.Taniguchi M, Saito K, Aida R, Ochiai A, Saitoh E, Tanaka T. Wound healing activity and mechanism of action of antimicrobial and lipopolysaccharide-neutralizing peptides from enzymatic hydrolysates of rice bran proteins. J Biosci Bioeng. 2019;128:142–8.

61.Fan YV, Lee CT, Klemeš JJ, Chua LS, Sarmidi MR, Leow CW. Evaluation of effective microorganisms on home scale organic waste composting. J Environ Manage. 2018;216:41–8.

62.Podnos YD, Wagman LD. The surgeon and palliative care. Ann Surg Oncol. 2007;14:1257–63.

63.Rai M, Spratt D, Gomez-Pereira PR, Patel J, Nair SP. Light activated antimicrobial agents can inactivate oral malodour causing bacteria. J Breath Res. 2016;10:046009.

64.Kasić S, Knezović M, Beader N, Gabrić D, Malčić AI, Baraba A. Efficacy of three different lasers on eradication of enterococcus faecalis and Candida albicans biofilms in root canal system. Photomed Laser Surg. 2017;35:372–7.

65.Bernardi S, Continenza MA, Al-Ahmad A, Karygianni L, Follo M, Filippi A, et al.  Streptococcus spp. and fusobacterium nucleatum in tongue dorsum biofilm from halitosis patients: a fluorescence in situ hybridization (FISH) and confocal laser scanning microscopy (CLSM) study. New Microbiol. 2019;42:108–13.

66.Krespi YP, Kizhner V, Wilson KA, Sivriver A, Low S, Khosravi Y, et al.  Laser tongue debridement for oral malodor-a novel approach to halitosis. Am J Otolaryngol. 2021;42:102458.

67.Namias N, Varela JE, Varas RP, Quintana O, Ward CG. Biodebridement: a case report of maggot therapy for limb salvage after fourth-degree burns. J Burn Care Rehabil. 2000;21:254–7.

68.Vistnes LM, Lee R, Ksander GA. Proteolytic activity of blowfly larvae secretions in experimental burns. Surgery. 1981;90:835–41.

69.Sherman RA, Shapiro CE, Yang RM. Maggot therapy for problematic wounds: uncommon and off-label applications. Adv Skin Wound Care. 2007;20:602–10.

70.Mumcuoglu KY. Clinical applications for maggots in wound care. Am J Clin Dermatol. 2001;2:219–27.

71.Contreras-Ruiz J, Fuentes-Suárez A, Arroyo-Escalante S, Moncada-Barron D, Sosa-de-Martínez MC, Maravilla-Franco E, et al.  Comparative study of the efficacy of larva therapy for debridement and control of bacterial burden compared to surgical debridement and topical application of an antimicrobial. Gac Med Mex. 2016;152:78–87.